Neuronetics, Inc.·4

Mar 18, 4:34 PM ET

MACAN WILLIAM ANDREW 4

4 · Neuronetics, Inc. · Filed Mar 18, 2026

Research Summary

AI-generated summary of this filing

Updated

Neuronetics (STIM) EVP William Macan Receives 33,750-Share Award

What Happened
William (William Andrew) Macan, EVP, Chief Legal Officer and Corporate Secretary of Neuronetics, was granted 33,750 shares on 2026-03-17 as an award (Form 4 transaction code A). The shares were issued at $0.00 per share (total reported value $0) pursuant to performance-based restricted stock units that vested when performance criteria were met.

Key Details

  • Transaction date: 2026-03-17; Form 4 filed: 2026-03-18 (next-day filing).
  • Type: Award/Grant of common stock (code A).
  • Shares received: 33,750; price per share: $0.00; total reported value: $0.
  • Footnote: Common stock issued for no consideration upon satisfaction of performance criteria underlying performance-based RSUs.
  • Shares owned after transaction: not disclosed in the provided filing.
  • Filing timeliness: Not marked late; filed the day after the transaction.

Context
This was an award vesting (performance-based RSUs), not an open-market purchase or sale. Such grants reflect achievement of internal performance goals and typically include vesting or transfer restrictions and tax implications; they do not necessarily signal immediate insider buying or selling intent. For investors, awards confirm management met certain targets but should be considered alongside other insider activity and company fundamentals.

Insider Transaction Report

Form 4
Period: 2026-03-17
MACAN WILLIAM ANDREW
EVP, CLO and CS
Transactions
  • Award

    Common Stock

    [F1]
    2026-03-17+33,750913,275 total
Footnotes (1)
  • [F1]Common stock received for no consideration upon the satisfaction of performance criteria underlying an award of performance based restricted stock units.
Signature
/s/ Patrick Devine, as Attorney-in-Fact|2026-03-18

Documents

1 file
  • 4
    ownership.xmlPrimary

    4